Your browser doesn't support javascript.
loading
miR-29c regulates resistance to paclitaxel in nasopharyngeal cancer by targeting ITGB1.
Huang, Limin; Hu, Chaoquan; Chao, Hui; Wang, Rongpin; Lu, He; Li, Hong; Chen, Hui.
Afiliação
  • Huang L; Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China. Electronic address: liminhuang7610@outlook.com.
  • Hu C; Department of Surgery, Affiliated Hospital, GuiZhou Medical University, 550004 Guiyang, China.
  • Chao H; Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Wang R; Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Lu H; INSERM UMR_S 1165/Paris 7, Hôpital Saint Louis, Paris, France.
  • Li H; INSERM UMR_S 1165/Paris 7, Hôpital Saint Louis, Paris, France. Electronic address: li.lu-hong@univ-rouen.fr.
  • Chen H; Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China. Electronic address: 1728436708@qq.com.
Exp Cell Res ; 378(1): 1-10, 2019 05 01.
Article em En | MEDLINE | ID: mdl-30779921
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Integrina beta1 / MicroRNAs / Antineoplásicos Limite: Humans Idioma: En Revista: Exp Cell Res Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Integrina beta1 / MicroRNAs / Antineoplásicos Limite: Humans Idioma: En Revista: Exp Cell Res Ano de publicação: 2019 Tipo de documento: Article